511 related articles for article (PubMed ID: 25922089)
1. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
2. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.
Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A
Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528
[TBL] [Abstract][Full Text] [Related]
3. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
[TBL] [Abstract][Full Text] [Related]
4. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil.
Aqil M; Ali A; Sultana Y; Najmi AK
Pharmazie; 2004 Aug; 59(8):631-5. PubMed ID: 15378854
[TBL] [Abstract][Full Text] [Related]
5. Hot melt extruded transdermal films based on amorphous solid dispersions in Eudragit RS PO: The inclusion of hydrophilic additives to develop moisture-activated release systems.
Albarahmieh E; Qi S; Craig DQM
Int J Pharm; 2016 Nov; 514(1):270-281. PubMed ID: 27863672
[TBL] [Abstract][Full Text] [Related]
6. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
Rastogi V; Yadav P; Husain A; Verma A
Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
[TBL] [Abstract][Full Text] [Related]
7. Design of antihistaminic transdermal films based on alginate-chitosan polyelectrolyte complexes: characterization and permeation studies.
Lefnaoui S; Moulai-Mostefa N; Yahoum MM; Gasmi SN
Drug Dev Ind Pharm; 2018 Mar; 44(3):432-443. PubMed ID: 29098871
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of patches for transdermal delivery of losartan potassium.
Baviskar DT; Parik VB; Gupta HN; Maniyar AH; Jain DK
PDA J Pharm Sci Technol; 2012; 66(2):126-35. PubMed ID: 22492598
[TBL] [Abstract][Full Text] [Related]
9. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.
Gannu R; Vishnu YV; Kishan V; Rao YM
Curr Drug Deliv; 2007 Jan; 4(1):69-76. PubMed ID: 17269919
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
11. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
[TBL] [Abstract][Full Text] [Related]
12. Formulation of Polymers-Based Methotrexate Patches and Investigation of the Effect of Various Penetration Enhancers: In Vitro, Ex Vivo and In Vivo Characterization.
Latif MS; Nawaz A; Rashid SA; Akhlaq M; Iqbal A; Khan MJ; Khan MS; Lim V; Alfatama M
Polymers (Basel); 2022 May; 14(11):. PubMed ID: 35683883
[TBL] [Abstract][Full Text] [Related]
13. EFFECT OF HYDROPHILIC AND HYDROPHOBIC POLYMER ON IN VITRO DISSOLUTION AND PERMEATION OF BISOPROLOL FUMARATE THROUGH TRANSDERMAL PATCH.
Shabbir M; Ali S; Raza M; Sharif A; Akhtar FM; Manan A; Fazli AR; Younas N; Manzoor I
Acta Pol Pharm; 2017 Jan; 74(1):187-197. PubMed ID: 29474775
[TBL] [Abstract][Full Text] [Related]
14. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan.
Subedi RK; Ryoo JP; Moon C; Choi HK
Int J Pharm; 2011 Oct; 419(1-2):209-14. PubMed ID: 21843607
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug.
Patel NA; Patel NJ; Patel RP
Drug Dev Ind Pharm; 2009 Feb; 35(2):234-42. PubMed ID: 18785045
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and evaluation of Eudragit
Chantasart D; Tocanitchart P; Wongrakpanich A; Teeranachaideekul V; Junyaprasert VB
Pharm Dev Technol; 2018 Oct; 23(8):771-779. PubMed ID: 28406344
[TBL] [Abstract][Full Text] [Related]
17. Matrix-type transdermal films to enhance simvastatin ex vivo skin permeability.
El-Say KM; Ahmed OA; Aljaeid BM; Zidan AS
Pharm Dev Technol; 2017 Jun; 22(4):492-499. PubMed ID: 26512747
[TBL] [Abstract][Full Text] [Related]
18. Formulation, optimization, and evaluation of a transdermal patch of heparin sodium.
Patel RP; Gaiakwad DR; Patel NA
Drug Discov Ther; 2014 Aug; 8(4):185-93. PubMed ID: 25262597
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of anti-rheumatic dexibuprofen transdermal patches: a quality-by-design approach.
Akhlaq M; Arshad MS; Mudassir AM; Hussain A; Kucuk I; Haj-Ahmad R; Rasekh M; Ahmad Z
J Drug Target; 2016 Aug; 24(7):603-12. PubMed ID: 26586147
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo permeation kinetics of zidovudine from pseudolatex acrylic film across pig ear epidermis.
Das MK; Yelhounganba Khuman L
Curr Drug Deliv; 2012 Sep; 9(5):468-76. PubMed ID: 22758649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]